Delivery Order SPE2DB22D2206-SPE2DB25FEE48

Award Date 11/12/24
Potential Completion Date 12/4/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,141.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TECVAYLI 30 MG/3 ML VIAL 3ML, a pharmaceutical product, to support defense and military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 27, 2025. AmerisourceBergen holds...
This federal contract award, valued at $6,161.92, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The contract is a firm-fixed-price delivery order with a period of performance through December 31, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that holds several Indefinite Delivery Contracts (IDCs) with federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The $23,824.28 firm-fixed-price delivery order has an ultimate completion date of August 13, 2024. This award is under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,868.12, is for the delivery of the drug Tecvayli (153 mg/1.7 mL vial) to support military healthcare programs. The contract does not have a set-aside designation, indicating it was open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $29,780.35, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a pharmaceutical product. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $59,928.80 firm fixed price delivery order is for the supply of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a pharmaceutical product, with a completion date of January 18, 2024. Amerisourcebergen Drug Corp has received numerous federal contract awards from DLA to provide...
This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The $26,577.85 contract is for the supply of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a pharmaceutical product, with a period of performance through February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This contract is issued under an indefinite delivery contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,963.18 Firm Fixed Price delivery order contract covers the supply of TALVEY 40 MG/ML VIALML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of April 9, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,963.18 firm fixed-price delivery order is for the supply of 'TALVEY 40 MG/ML VIALML' medical products. The contract has an ultimate completion date of March 6, 2025 and is not set aside for any specific business category. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order valued at $21,261.50 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract provides for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEE48
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,912.14 firm fixed-price delivery order is for the drug TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, with a period of performance through December 4, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This order represents one of many federal contract awards to AmerisourceBergen, demonstrating the company's critical role in supplying essential medical commodities across various therapeutic areas to key government healthcare agencies and military treatment facilities.

Generated 2/11/25, 10:36 AM